MARK W. BURNS, MD
Urology at Sand Point Way, Seattle, WA
License number
Washington MD00018974
Category
Radiology
Type
Urology
Address
Address
4540 Sand Point Way NE STE 120, Seattle, WA 98105
Phone
(206) 215-2900
(206) 215-2929 (Fax)
(206) 215-2929 (Fax)
Personal information
See more information about MARK W. BURNS at radaris.comName
Address
Phone
3922 Pueblo Hts, Mount Vernon, WA 98273
26253 172Nd Ave SE, Kent, WA 98042
14401 Petrovitsky Rd, Renton, WA 98058
Organization information
See more information about MARK W. BURNS at bizstanding.comMark W Burns MD
4800 Sand Pt Way NE #MSW98, Seattle, WA 98105
Categories:
Urology Physicians & Surgeons
Phone:
(206) 987-2000 (Phone)
Professional information
See more information about MARK W. BURNS at trustoria.com
Dr. Mark W Burns, Seattle WA - MD (Doctor of Medicine)
Dr. Mark W Burns, Seattle WA - MD (Doctor of Medicine)
Specialties:
Urology
Address:
4800 Sand Point Way NE SUITE 120, Seattle 98105
(206) 215-2900 (Phone), (206) 215-2929 (Fax)
(206) 215-2900 (Phone), (206) 215-2929 (Fax)
Certifications:
Urology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
4800 Sand Point Way NE SUITE 120, Seattle 98105
Swedish Medical Center/First Hill
747 Broadway, Seattle 98122
EvergreenHealth Medical Center
12040 East 128Th St, Kirkland 98034
Swedish Medical Center/First Hill
747 Broadway, Seattle 98122
EvergreenHealth Medical Center
12040 East 128Th St, Kirkland 98034
Education:
Medical School
University of Washington
Graduated: 1979
University Of Washington
Graduated: 1981
Hospital Sick Chldn
Graduated: 1986
University of Washington
Graduated: 1979
University Of Washington
Graduated: 1981
Hospital Sick Chldn
Graduated: 1986
Mark W Burns, Seattle WA
Mark W Burns, Seattle WA
Specialties:
Urologist
Address:
4800 Sand Point Way Ne, Seattle, WA 98105
Education:
University of Washington, School of Medicine - Doctor of Medicine
The Hospital for Sick Children (SickKids) - Fellowship - Pediatric Urology (Urology)
University of Washington Medical Center - Residency - Urology
University of Washington Medical Center - Residency - Surgery
The Hospital for Sick Children (SickKids) - Fellowship - Pediatric Urology (Urology)
University of Washington Medical Center - Residency - Urology
University of Washington Medical Center - Residency - Surgery
Board certifications:
American Board of Urology Certification in Urology
Mark W Burns, Seattle WA
Mark W Burns, Seattle WA
Specialties:
Urology
Work:
Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105 Childrens Univ Med Grp
1959 Ne Pacific St, Seattle, WA 98195 Seattle Children's Bellevue Clinic and Surgery Center
1500 116Th Ave NE, Bellevue, WA 98004
4800 Sand Point Way NE, Seattle, WA 98105 Childrens Univ Med Grp
1959 Ne Pacific St, Seattle, WA 98195 Seattle Children's Bellevue Clinic and Surgery Center
1500 116Th Ave NE, Bellevue, WA 98004
Education:
University of Washington (1979)
Polyamine Analogues As Therapeutic And Diagnostic Agents
Polyamine Analogues As Therapeutic And Diagnostic Agents
US Patent:
6646149, Nov 11, 2003
Filed:
May 31, 2000
Appl. No.:
09/584175
Inventors:
Nicolaas M. J. Vermeulin - Woodinville WA 98072
Christine L. ODay - Mountlake Terrace WA 98043
Heather K. Webb - Seattle WA 98107
Mark R. Burns - Shoreline WA 98177
Donald E. Bergstrom - West Lafayette IN 47906
Christine L. ODay - Mountlake Terrace WA 98043
Heather K. Webb - Seattle WA 98107
Mark R. Burns - Shoreline WA 98177
Donald E. Bergstrom - West Lafayette IN 47906
International Classification:
C07C27112
US Classification:
560 25, 549 65, 549560, 564 83, 564 84, 564215, 514269, 514270, 514290, 514299, 514354, 514361, 514378, 514445, 514468, 514478, 514520, 514561, 514602, 514616, 514629, 514673, 514674, 544300, 546101, 546152, 548127, 548248, 548537, 558411
Abstract:
Novel âbispolyamineâ inhibitor compounds of polyamine transport are disclosed. These compounds are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins, for example cancer and post-angioplasty injury. These compounds display desirable activities both for diagnostic and research assays and therapy.
Polyamine Analogs That Activate Antizyme Frameshifting
Polyamine Analogs That Activate Antizyme Frameshifting
US Patent:
7144920, Dec 5, 2006
Filed:
Mar 29, 2004
Appl. No.:
10/810649
Inventors:
Mark R. Burns - Shoreline WA, US
Gerard F. Graminski - Shoreline WA, US
Gerard F. Graminski - Shoreline WA, US
Assignee:
MediQuest Therapeutics, Inc. - Bothell WA
International Classification:
A61K 31/135, C07D 211/18
US Classification:
514649, 564336
Abstract:
Novel polyamines, their synthesis and use in pharmacological, cosmetic or agricultural applications are provided. The polyamines induce antizyme production which in turn down regulates both the production of polyamines by omithine decarboxylase (ODC) and the transport of polyamines by its corresponding polyamine transporter. These compounds will preferably enter the cell independent of the polyamine transporter. As drugs, these compounds are used to treat any disease associated with cellular proliferation including but not limited to cancer.
Polyamine Analogues As Therapeutic And Diagnostic Agents
Polyamine Analogues As Therapeutic And Diagnostic Agents
US Patent:
7160923, Jan 9, 2007
Filed:
Nov 14, 2000
Appl. No.:
09/713512
Inventors:
Nicolaas M. J. Vermeulin - Woodinville WA, US
Christine L. O'Day - Mountlake Terrace WA, US
Heather K. Webb - Seattle WA, US
Mark R. Burns - Shoreline WA, US
Donald E. Bergstrom - West Lafayette IN, US
Christine L. O'Day - Mountlake Terrace WA, US
Heather K. Webb - Seattle WA, US
Mark R. Burns - Shoreline WA, US
Donald E. Bergstrom - West Lafayette IN, US
Assignee:
MediQuest Therapeutics, Inc. - Bothell WA
International Classification:
A61K 31/27, A61K 31/18, A61K 31/165, A61K 31/17, A61K 31/34
US Classification:
514626, 514311, 514365, 514378, 514423, 514445, 514471, 514481, 514596, 514602, 514603, 514616, 514617, 514625, 544144, 548200, 548243, 5483251, 548536, 549479, 560157, 564 48, 564 80, 564 83, 564 84, 564 86, 564161, 564180, 564197
Abstract:
Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins, for example cancer and post-angioplasty injury. Novel chemical synthetic methods to obtain polyamine analogues are disclosed, including the production of a combinatiorial polyamine library. These approaches yield analogues with desirable activities both for diagnostic and research assays and therapy. The assays of the invention are useful for high throughput screening of targets in the discovery of drugs that interact with the polyamine system.
Polyamine Analogs That Activate Antizyme Frameshifting
Polyamine Analogs That Activate Antizyme Frameshifting
US Patent:
6914079, Jul 5, 2005
Filed:
Sep 23, 2002
Appl. No.:
10/251819
Inventors:
Mark R. Burns - Shoreline WA, US
Gerard F. Graminski - Shoreline WA, US
Gerard F. Graminski - Shoreline WA, US
Assignee:
MediQuest Therapeutics, Inc. - Seattle WA
International Classification:
A61K031/135, C07C211/27
US Classification:
514646, 514645, 564305, 564306, 564336
Abstract:
Novel polyamines, their synthesis and use in pharmacological, cosmetic or agricultural applications are provided. The polyamines induce antizyme production which in turn down regulates both the production of polyamines by ornithine decarboxylase (ODC) and the transport of polyamines by its corresponding polyamine transporter. These compounds will preferably enter the cell independent of the polyamine transporter. As drugs, these compounds are used to treat any disease associated with cellular proliferation including but not limited to cancer.
Polyamine Analogues As Therapeutic And Diagnostic Agents
Polyamine Analogues As Therapeutic And Diagnostic Agents
US Patent:
6172261, Jan 9, 2001
Filed:
Sep 3, 1999
Appl. No.:
9/341400
Inventors:
Nicolaas M. J. Vermeulin - Woodinville WA
Christine L. O'Day - Mountlake Terrace WA
Heather K. Webb - Seattle WA
Mark R. Burns - Shoreline WA
Donald E. Bergstrom - West Lafayette IN
Christine L. O'Day - Mountlake Terrace WA
Heather K. Webb - Seattle WA
Mark R. Burns - Shoreline WA
Donald E. Bergstrom - West Lafayette IN
Assignee:
Oridigm Corporation - Seattle WA
International Classification:
C07C30300
US Classification:
564 84
Abstract:
Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins, for example cancer and post-angioplasty injury. Novel chemical synthetic methods to obtain polyamine analogues are disclosed, including the production of a combinational polyamine library. These approaches yield analogues with desirable activities both for diagnostic and research assays and therapy. The assays of the invention are useful for high throughput screening of targets in the discovery of drugs that interact with the polyamine system.
Polyamine Analogues As Cytotoxic Agents
Polyamine Analogues As Cytotoxic Agents
US Patent:
6872852, Mar 29, 2005
Filed:
Mar 23, 2001
Appl. No.:
10/239521
Inventors:
Mark R. Burns - Shoreline WA, US
Assignee:
MediQuest Therapeutics, Inc. - Bothell WA
International Classification:
C07C211/09, C07C211/13, A61K031/135
US Classification:
564306, 564338, 564367, 564372, 514649, 514650
Abstract:
Cytotoxic polyamine analogues are provided that are useful for treating diseases where it is desired to inhibit cell growth and/or proliferation, for example cancer and post-angioplasty injury.
